Results 71 to 80 of about 44,270 (170)

Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer. [PDF]

open access: yesAm J Cancer Res, 2021
Staley A   +14 more
europepmc   +1 more source

The World of GPCR dimers - Mapping dopamine receptor D2 homodimers in different activation states and configuration arrangements. [PDF]

open access: yesComput Struct Biotechnol J, 2023
Bueschbell B   +6 more
europepmc   +1 more source

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer. [PDF]

open access: yesJ Exp Clin Cancer Res, 2021
Pierce SR   +19 more
europepmc   +1 more source

Dopamine D2 receptor [PDF]

open access: yesScience-Business eXchange, 2008
openaire   +1 more source

Home - About - Disclaimer - Privacy